跳至主要内容
临床试验/NL-OMON21326
NL-OMON21326招募中不适用

Minimally invasive, Indocyanine-Guided Metastasectomy in patients with Colorectal Liver Metastases

one0 个研究点目标入组 186 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
one
入组人数
186

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 18 years or older
  • Patients with colorectal liver metastases (primary and recurrent CRLM) planned for curative-intent minimally invasive surgery, either laparoscopic or robotic resection
  • Patients eligible for indocyanine infusion 24h prior to surgery according to the hospitals protocol
  • Patients with or without neoadjuvant chemotherapy (for primary and/or secondary colorectal tumor/metastases)

排除标准

  • Patients with contraindications for Indocyanine green:
  • o Iodide allergy of allergies for shells and/or clamps
  • o Impaired kidney function (eGRF <50)
  • Local recurrent CRLM at the site of previous ablative therapy

研究者

发起方
one

相似试验